82 related articles for article (PubMed ID: 30940480)
21. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review.
Gómez Rivas J; Carrion DM; Chandrasekar T; Álvarez-Maestro M; Enikeev D; Martínez-Piñeiro L; Barret E
Actas Urol Esp (Engl Ed); 2021 Apr; 45(3):188-197. PubMed ID: 33189417
[TBL] [Abstract][Full Text] [Related]
22. The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.
Schulman AA; Sze C; Tsivian E; Gupta RT; Moul JW; Polascik TJ
Curr Urol Rep; 2017 Jul; 18(7):52. PubMed ID: 28589398
[TBL] [Abstract][Full Text] [Related]
23. Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.
Fam MM; Yabes JG; Macleod LC; Bandari J; Turner RM; Lopa SH; Furlan A; Filson CP; Davies BJ; Jacobs BL
Urology; 2019 Aug; 130():99-105. PubMed ID: 30940480
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.
Chu CE; Lonergan PE; Washington SL; Cowan JE; Shinohara K; Westphalen AC; Carroll PR; Cooperberg MR
Eur Urol; 2020 Oct; 78(4):515-517. PubMed ID: 32631744
[TBL] [Abstract][Full Text] [Related]
26. Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.
Mamawala MK; Meyer AR; Landis PK; Macura KJ; Epstein JI; Partin AW; Carter BH; Gorin MA
BJU Int; 2020 Jun; 125(6):861-866. PubMed ID: 32039537
[TBL] [Abstract][Full Text] [Related]
27. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
[TBL] [Abstract][Full Text] [Related]
29. National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.
Modi PK; Kaufman SR; Qi J; Lane BR; Cher ML; Miller DC; Hollenbeck BK; Shahinian VB; Dupree JM
Urology; 2018 Oct; 120():96-102. PubMed ID: 29990573
[TBL] [Abstract][Full Text] [Related]
30. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
Carroll PH; Mohler JL
J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
[TBL] [Abstract][Full Text] [Related]
31. Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
Curci NE; Lane BR; Shankar PR; Noyes SL; Moriarity AK; Kubat A; Brede C; Montgomery JS; Auffenberg GB; Miller DC; Montie JE; George AK; Davenport MS
Urology; 2018 Jun; 116():137-143. PubMed ID: 29653121
[TBL] [Abstract][Full Text] [Related]
32. Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?
Bryant RJ; Yang B; Philippou Y; Lam K; Obiakor M; Ayers J; Chiocchia V; Gleeson F; MacPherson R; Verrill C; Sooriakumaran P; Hamdy FC; Brewster SF
BJU Int; 2018 Nov; 122(5):794-800. PubMed ID: 29645347
[TBL] [Abstract][Full Text] [Related]
33. Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect.
Perlis N; Al-Kasab T; Ahmad A; Goldberg E; Fadak K; Sayyid R; Finelli A; Kulkarni G; Hamilton R; Zlotta A; Ghai S; Fleshner N
J Urol; 2018 May; 199(5):1182-1187. PubMed ID: 29175542
[TBL] [Abstract][Full Text] [Related]
34. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
35. Incidental findings on multiparametric MRI performed for evaluation of prostate cancer.
Sherrer RL; Lai WS; Thomas JV; Nix JW; Rais-Bahrami S
Abdom Radiol (NY); 2018 Mar; 43(3):696-701. PubMed ID: 28677001
[TBL] [Abstract][Full Text] [Related]
36. Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.
Gökce MI; Sundi D; Schaeffer E; Pettaway C
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):127-136. PubMed ID: 28417980
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Ahmed HU; El-Shater Bosaily A; Brown LC; Gabe R; Kaplan R; Parmar MK; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham AP; Oldroyd R; Parker C; Emberton M;
Lancet; 2017 Feb; 389(10071):815-822. PubMed ID: 28110982
[TBL] [Abstract][Full Text] [Related]
38. INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer.
Johnston E; Pye H; Bonet-Carne E; Panagiotaki E; Patel D; Galazi M; Heavey S; Carmona L; Freeman A; Trevisan G; Allen C; Kirkham A; Burling K; Stevens N; Hawkes D; Emberton M; Moore C; Ahmed HU; Atkinson D; Rodriguez-Justo M; Ng T; Alexander D; Whitaker H; Punwani S
BMC Cancer; 2016 Oct; 16(1):816. PubMed ID: 27769214
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
